| Literature DB >> 11720477 |
M J Stassar1, G Devitt, M Brosius, L Rinnab, J Prang, T Schradin, J Simon, S Petersen, A Kopp-Schneider, M Zöller.
Abstract
Renal cell carcinoma (RCC) are frequently chemo- and radiation resistant. Thus, there is a need for identifying biological features of these cells that could serve as alternative therapeutic targets. We performed suppression subtractive hybridization (SSH) on patient-matched normal renal and RCC tissue to identify variably regulated genes. 11 genes were strongly up-regulated or selectively expressed in more than one RCC tissue or cell line. Screening of filters containing cancer-related cDNAs confirmed overexpression of 3 of these genes and 3 additional genes were identified. These 14 differentially expressed genes, only 6 of which have previously been associated with RCC, are related to tumour growth/survival (EGFR, cyclin D1, insulin-like growth factor-binding protein-1 and a MLRQ sub-unit homologue of the NADH:ubiquinone oxidoreductase complex), angiogenesis (vascular endothelial growth factor, endothelial PAS domain protein-1, ceruloplasmin, angiopoietin-related protein 2) and cell adhesion/motility (protocadherin 2, cadherin 6, autotaxin, vimentin, lysyl oxidase and semaphorin G). Since some of these genes were overexpressed in 80-90% of RCC tissues, it is important to evaluate their suitability as therapeutic targets. Copyright 2001 Cancer Research CampaignEntities:
Mesh:
Substances:
Year: 2001 PMID: 11720477 PMCID: PMC2375251 DOI: 10.1054/bjoc.2001.2074
Source DB: PubMed Journal: Br J Cancer ISSN: 0007-0920 Impact factor: 7.640